About WuXi Biologics (Cayman) Inc
WuXi Biologics is a Chinese contract research, development and manufacturing organisation (CRDMO) that provides end-to-end solutions to the global biologics market. Its open-access platform comes with a variety of capabilities and technologies and is used by partners across the world, supporting more than 500 integrated projects for the purpose of benefitting patients. The company was founded in 2015 with headquarters in Jiangsu. WuXi Biologics employs over 10,000 people across China, the US, Ireland, Germany and Singapore for its manufacturing sites and regional offices. It also offers biosafety and analytical testing services, as well as quality assurance and control services. WuXi Biologics stock is listed on the Hong Kong Stock Exchange and is a constituent of the Hang Seng index. Start spread betting or trading CFDs on our WuXi Biologics share price.
Why 300,000 committed global clients† choose CMC
-
Tax-free profits on spread bets. No stamp duty on CFDs^
-
Access to 12,000+ financial instruments
-
99.95%+ platform stability**
-
99.9% fill rate with 0.0029s execution*
-
London-Based Client Support
Constituent weightings
Component |
Weighting |
1 Day |
1 Month |
3 Month |
Trading hours
(shown in London local time )